cvs health glp-1 receptor agonists weight management diabetes treatments MinuteClinic Weight-Loss Program expands access to care Weight Loss Management for Men

doi: 10.3389/fimmu.2023.1148209

[DOI] [PubMed] [Google Scholar] 70.Rangaswami J., Bhalla V., Blair J.E.A., Chang T.I., Costa S., Krista L.L., Lerma E.V., Mezue K., Molitch M., Mullens W., et al

Supplements like berberine dont work the same way and wont produce similar results

People without diabetes lost more weight at every dose People with diabetes saw greater glycemic improvement This suggests: Baseline insulin resistance Concomitant medications Metabolic flexibility all likely influence response

Obesity is a risk factor for a broad spectrum of diseases, including cardiovascular disease

A comprehensive meta-analysis of eight GLP-1 RA CVOTs revealed several critical findings: 14% reduction in major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) [3] 13% reduction in cardiovascular death [3] 10% reduction in all-cause mortality [3] 11% reduction in hospitalization for heart failure [3] Post-hoc analyzes from LEADER and SUSTAIN-6 revealed that cardiovascular benefits extended across the spectrum of body mass index categories, indicating efficacy regardless of baseline weight [2]